Valuation: Recordati SpA

Market Cap 10.77B 12.13B 10.05B 9.16B 17.28B 1,166B 17.45B 122B 47.15B 596B 45.52B 44.54B 1,912B P/E 2026 *
21.3x
P/E 2027 * 17.4x
Enterprise Value 12.54B 14.11B 11.7B 10.67B 20.12B 1,357B 20.3B 142B 54.88B 694B 52.98B 51.83B 2,226B EV / Sales 2026 *
4.49x
EV / Sales 2027 * 4.04x
Free-Float
50.46%
Yield 2026 *
2.9%
Yield 2027 * 3.2%
Manager TitleAgeSince
Chief Executive Officer 64 01/12/2021
Director of Finance/CFO 56 01/01/2026
Chief Tech/Sci/R&D Officer 56 01/10/2023
Director TitleAgeSince
Chairman 54 01/12/2021
Chairman 57 12/06/2018
Director/Board Member 53 12/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
-0.61%-3.43%+36.07%+115.04% 1,019B
-1.02%-5.60%+35.72%+64.63% 617B
+1.11%-0.58%+12.36%+77.95% 464B
+0.34%-3.01%+61.79%+41.24% 356B
+1.14%-1.44%+21.46%+41.99% 333B
+1.06%-3.00%+11.30%+35.00% 267B
+0.51%-4.51%-6.27%+9.41% 244B
-1.04%-2.79%+35.30%+51.84% 218B
-1.87%-4.10%+28.44%+93.66% 179B
Average +0.02%-3.54%+26.24%+58.97% 410.8B
Weighted average by Cap. +0.02%-3.54%+29.20%+70.78%

Financials

2026 *2027 *
Net sales 2.79B 3.14B 2.61B 2.38B 4.48B 302B 4.52B 31.54B 12.22B 154B 11.8B 11.54B 496B 3.03B 3.41B 2.83B 2.58B 4.86B 328B 4.9B 34.2B 13.25B 167B 12.79B 12.52B 537B
Net income 570M 642M 532M 485M 915M 61.7B 923M 6.44B 2.5B 31.54B 2.41B 2.36B 101B 684M 770M 639M 582M 1.1B 74.02B 1.11B 7.73B 2.99B 37.84B 2.89B 2.83B 121B
Net Debt 1.77B 1.99B 1.65B 1.5B 2.83B 191B 2.86B 19.94B 7.73B 97.65B 7.46B 7.3B 313B 1.45B 1.63B 1.35B 1.23B 2.33B 157B 2.35B 16.4B 6.35B 80.29B 6.13B 6B 258B
Logo Recordati SpA
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (58.7%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (41.3%). Net sales are distributed geographically as follows: Italy (12.6%), Europe (53.7%), America (23.1%), Asia and Oceania (7.8%) and Africa (2.8%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-